Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (1): 188-192. doi: 10.3969/j.issn.1671-167X.2018.01.032
• Article • Previous Articles Next Articles
SUN Hai-tao, YANG Rui-jie△, JIANG Ping, JIANG Wei-juan, LI Jin-na, MENG Na, WANG Jun-jie
CLC Number:
| [1] | Hai WANG, Yizhou JIANG. Molecular mechanisms and clinical applications of anti-angiogenic therapy in precision treatment of breast cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 251-256. |
| [2] | Miaoyu LIU, Siyuan WANG, Lin PEI, Shu WANG. Impact of concurrent use of goserelin on the efficacy of neoadjuvant chemotherapy in young breast cancer patients [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 291-297. |
| [3] | Xiao-juan ZHU,Hong ZHANG,Shuang ZHANG,Dong LI,Xin LI,Ling XU,Ting LI. Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 243-253. |
| [4] | LI Jun,LIU Xu-hong,WANG Gong,CHENG Cheng,ZHUANG Hong-qing,YANG Rui-jie. Dosimetric effect of patient arm position on Cyberknife radiosurgery for spinal tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 182-186. |
| [5] | Si-yuan WANG,Shu WANG. Anti-Müllerian hormone as a new marker of the ovarian reserve function preservation by goserelin during (neo)adjuvant chemotherapy for young breast cancer patients [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 536-541. |
|
||